Americans shelled out an estimated $71 billion for weight-loss drugs in 2023 - that is as much as the U.S. government ...

Initially developed to manage blood sugar levels in diabetic patients, GLP-1 agonists have gained popularity for their weight-reducing effects.

New research found hospital visits from Ozempic and Wegovy are rare, but can be serious. Experts explain the finding and ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...

“There is some evidence that there is altered brain activity related to reward-related behaviors, including appetite and ...

A “game-changing” Ozempic-style daily pill could transform public health in Britain, experts have said. The drug is expected ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

The agency and Novo Nordisk, which makes Ozempic, said Monday that they had learned about "several hundred units" of the drug ...